伊萨丁二二二醇混合物的新结构特征用于选择性碳酸无水酶抑制剂
Daniela Secci1, Simona Distinto1, Alessia Onali1
1Department of Life and Environmental Sciences, Cittadella Universitaria, University of Cagliari, sp8 09042 Monserrato, Cagliari 09124, Italy.
研究人员开发了新型的伊沙 thiazolidinone 杂交物,作为人类碳酸无水酶 (hCA) IX 和 XII 的强有力的抑制剂,这是癌症治疗中的关键标. 这些化合物显示出选择性抗癌药物开发的前景.
科学领域:
- 药用化学 医学化学
- 生物化学 生物化学
- 在瘤学瘤学.
背景情况:
- 化疗是晚期癌症的主要治疗方法.
- 人类碳酸胺酶 (hCA) 异型IX和XII是经过验证的抗癌标.
- 在各种固体瘤中hCA IX的过度表达,需要选择性抑制剂.
研究的目的:
- 设计和合成新型的伊沙 thiazolidinone 混合物.
- 评估它们对hCA异型I,II,IX和XII的抑制活性和选择性.
- 探索选择性hCA抑制的结构-活性关系.
主要方法:
- 合成了一系列新型的伊沙 thiazolidinone 混合物.
- 在体外生物评估抑制活性和对hCA异型的选择性.
- 分子对接研究,以预测结合模式.
主要成果:
- 化合物表现出对hCA IX和XII的纳米分子抑制活性.
- thiazolidinone 环上的替换模式对选择性产生了重大影响.
- 对hCA IX和XII而言,与其他异型相比,观察到有前途的选择性.
结论:
- 伊萨丁 thiazolidinone 杂交物为开发选择性hCA IX 和 XII 抑制剂提供了一个有前途的支架.
- 这些发现有助于开发新的抗癌药物.
- 进一步优化可能会导致强效和低毒性癌症疗法.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
12:27Synthesis of Hypervalent Iodonium Alkynyl Triflates for the Application of Generating Cyanocarbenes
Published on: September 8, 2013
相关概念视频
Antihypertensive Drugs: Thiazide-Class Diuretics
Regioselectivity and Stereochemistry of Acid-Catalyzed Hydration
Aldehydes and Ketones with HCN: Cyanohydrin Formation Overview
Structure of Conjugated Dienes
Conjugated dienes are compounds characterized by the presence of alternating double and single bonds. In a conjugated system like 1,3-butadiene, the unhybridized 2p orbital on each carbon overlaps continuously, allowing the π electrons to be delocalized across the entire molecule. In contrast, this type of overlap does not occur in cumulated and isolated dienes, such as 2,3-pentadiene and 1,4-pentadiene, respectively. Instead, the π electrons remain localized between the double...
Aldehydes and Ketones with HCN: Cyanohydrin Formation Mechanism
Basicity of Heterocyclic Aromatic Amines
